Drug
Who makes ioflupane i-123?
2 companies list ioflupane i-123 as a human prescription drug, including under the names DaTscan. Forms: injection, solution. Routes: intravenous.
Labellers from the openFDA NDC Directory. A labeller is the firm named on the label, not necessarily the site that made the product, and a listing is not an FDA approval. Data as of 24 Sept 2026. Methodology
Companies listing ioflupane i-123
| Company | Forms | Application | NDCs | Registered sites |
|---|---|---|---|---|
| Curium US LLCUnited States | injection, solution | ANDAANDA213792 | 1 | 3 |
| Medi-Physics, Inc. dba GE Healthcare | injection, solution | NDANDA022454 | 1 | 0 |
Enquiry
Common questions
- Who makes ioflupane i-123?
- 2 companies list ioflupane i-123 as a human prescription drug in the openFDA NDC Directory, led by Curium US LLC, Medi-Physics, Inc. dba GE Healthcare. Each is the labeller, the firm named on the label; the product may be made at a site registered to another company.
- Is there a generic DaTscan?
- 1 company lists ioflupane i-123 under an abbreviated new drug application (ANDA), the application type used for generics, and 1 under an NDA or BLA. Listing status is from the NDC Directory; it is not a statement of availability.